Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial

Karin Fjordén; Sara Ekberg; Nevzeta Kuric; Karin E Smedby; Ingemar Lagerlöf; Thomas S Larsen; Judit M Jørgensen; Peter de Nully Brown; Mats Jerkeman

doi:10.1111/bjh.17792

Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial

Karin Fjordén, Sara Ekberg, Nevzeta Kuric, Karin E Smedby, Ingemar Lagerlöf, Thomas S Larsen, Judit M Jørgensen, Peter de Nully Brown, Mats Jerkeman

Afdeling for Blodsygdomme CKO

10 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	British Journal of Haematology
Vol/bind	196
Udgave nummer	2
Sider (fra-til)	437-440
Antal sider	4
ISSN	0007-1048
DOI	https://doi.org/10.1111/bjh.17792
Status	Udgivet - jan. 2022

Adgang til dokumentet

10.1111/bjh.17792

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{2e64553f4f204d0096210513777b7fcb,

title = "Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial",

keywords = "Idelalisib, relapsed/refractory DLBCL, transformed lymphoma",

author = "Karin Fjord{\'e}n and Sara Ekberg and Nevzeta Kuric and Smedby, {Karin E} and Ingemar Lagerl{\"o}f and Larsen, {Thomas S} and J{\o}rgensen, {Judit M} and {de Nully Brown}, Peter and Mats Jerkeman",

year = "2022",

month = jan,

doi = "10.1111/bjh.17792",

language = "English",

volume = "196",

pages = "437--440",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc.",

number = "2",

}

TY - JOUR

T1 - Idelalisib in relapsed/refractory diffuse large B-cell lymphoma

T2 - results from a Nordic Lymphoma Group phase II trial

AU - Fjordén, Karin

AU - Ekberg, Sara

AU - Kuric, Nevzeta

AU - Smedby, Karin E

AU - Lagerlöf, Ingemar

AU - Larsen, Thomas S

AU - Jørgensen, Judit M

AU - de Nully Brown, Peter

AU - Jerkeman, Mats

PY - 2022/1

Y1 - 2022/1

KW - Idelalisib

KW - relapsed/refractory DLBCL

KW - transformed lymphoma

UR - http://www.scopus.com/inward/record.url?scp=85113305805&partnerID=8YFLogxK

U2 - 10.1111/bjh.17792

DO - 10.1111/bjh.17792

M3 - Letter

C2 - 34435356

SN - 0007-1048

VL - 196

SP - 437

EP - 440

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 2

ER -